Ozempic, a drug primarily used for treating type 2 diabetes, is facing global shortages due to its popularity in social media and its potential for weight loss. Developed by Danish pharmaceutical company Novo Nordisk, this injectable medication is found to slow down the rate at which food leaves the stomach, thereby reducing appetite.
The Weight Loss Potential of Ozempic
Ozempic has gained popularity in recent times for its potential as a weight loss drug. A peer-reviewed research found that nearly three-quarters of users lost over 10% of their body weight after taking Ozempic. This weight loss property has led to its widespread use in individuals looking for a weight loss drug.
Global Shortages
The popularity of Ozempic has led to global shortages of the medication. In a statement released in January, Novo Nordisk stated that the high demand for Ozempic was caused by the medication’s effectiveness in reducing the risk of cardiovascular disease in type 2 diabetes patients. The statement also attributed the shortages to supply chain disruptions due to the ongoing COVID-19 pandemic.
The Role of Social Media in Ozempic’s Popularity
The popularity of Ozempic can also be attributed to social media. Many users have taken to platforms such as Twitter and Instagram to share their experiences with the drug, with some even posting before and after photos of their weight loss journey.
However, this social media popularity has also led to concerns about the drug being misused for weight loss purposes, with some individuals taking the drug without proper medical supervision or using it for reasons other than its intended use.
Possible Side Effects
It is essential to note that Ozempic has potential side effects and should be used under proper medical supervision. Some of the side effects reported with the use of Ozempic include nausea, diarrhea, vomiting, constipation, and stomach pain. Additionally, there have been reports of a rare side effect called diabetic retinopathy, which affects the eyes.
Last Modified: February 20, 2024